Nick Glover is a biotech CEO, strategic adviser, and board director. They served as President & CEO of Sierra Oncology from 2014 to 2020 and have been CEO of MycRx since 2020, with consulting work through Dr. Nick Glover Consulting since 2008. Their current roles include strategic adviser positions at Phoenix Molecular Designs (since 2022), PDX Pharmaceuticals (since 2021), and a senior subject matter expert role at GLG (since 2023). They also serve on the boards of Pattern Pharma (since 2020) and MEI Pharma (since 2013), and hold a board seat at MycRx (since 2021). Earlier, they were Vice President, Corporate Development & Product Operations at Viventia Biotech (2000–2004) and Investment Manager/Science Analyst at MDS Capital (Lumira Ventures) (1998–2000).
This person is not in the org chart
This person is not in any teams
This person is not in any offices